Fonds De Solidarite Des Travailleurs Du Quebec's Form 4 filing
enGene Therapeutics Inc. (ENGN) · filed Apr 22, 2024
- Accession no.
- 0000950142-24-001171
- Filed
- Apr 22, 2024
- Trade date
- Apr 18-22, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market sales total $788.0K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Fonds De Solidarite Des Travailleurs Du QuebecCIK 0000903337 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 18, 2024 | Common shares | SSaleDisposed | −4,575 | $15.01 | −$68,670.75 | 3,084,107 | Direct | |
| Apr 19, 2024 | Common shares | SSaleDisposed | −100 | $15.00 | −$1,500 | 3,084,007 | Direct | |
| Apr 22, 2024 | Common shares | SSaleDisposed | −47,854 | $15.00 | −$717,810 | 3,036,153 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.